News Quantified

MCRB – seres therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Seres Therapeutics to Present at CARB-X Investor Day

Seres Therapeutics (MCRB) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $22.00 price target on the stock.

Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

-0.8%

BEAT

-7.5%

BEAT

-3.5%

BEAT

-2.0%

BEAT

Canaccord Genuity

Form 144 Seres Therapeutics, Inc. Filed by: Young Teresa L.

Form 8-K Seres Therapeutics, Inc. For: Mar 16

Form 10-K Seres Therapeutics, Inc. For: Dec 31

Form 8-K Seres Therapeutics, Inc. For: Mar 12

Form 4 Seres Therapeutics, Inc. For: Mar 04 Filed by: Brady Kelly

Top News Gainers

3/13 Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration’s March 12, 2020 Safety Alert Related to Use of Fecal Microbiota Transplantation 17.1%

3/18 Form 424B5 Seres Therapeutics, Inc. 14.2%

8/6 Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 12.2%

3/23 Seres Therapeutics Appoints Paul Biondi, Experienced Biopharmaceutical Strategy and Corporate Development Professional, to Its Board of Directors 9.7%

3/30 Seres Therapeutics Announces Completion of Enrollment in SER-109 Phase 3 ECOSPOR III Study for Recurrent Clostridium difficile Infection and Provides Clinical Pipeline Updates 9.5%

4/6 Seres Therapeutics Appoints Lisa von Moltke, M.D., as Chief Medical Officer 9.2%

11/5 Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 8.8%

3/15 Seres Therapeutics to Virtually Present at the Chardan Microbiome Medicines Summit 8.8%

6/14 Form 4 Seres Therapeutics, Inc. For: Jun 13 Filed by: Kim Lorence H. 7.5%

4/24 Form 4 Seres Therapeutics, Inc. For: Apr 22 Filed by: Chapman Marcus 6.9%

Top News Decliners

6/13 Seres Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock -20.3%

3/17 Seres Therapeutics (MCRB) Presents At Cowen and Comapny 40th Annual Health Care Conference - Slideshow [Seeking Alpha] -9.6%

6/28 Form 3 Seres Therapeutics, Inc. For: Jun 18 Filed by: Nutritional Health LTP Fund General Partner LLC -8.4%

11/5 Seres Therapeutics Inc (MCRB) Q3 2019 Earnings Call Transcript [The Motley Fool] -8.1%

11/27 Form 424B5 Seres Therapeutics, Inc. -8.1%

5/11 Seres Therapeutics Inc (NASDAQ: MCRB) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -7.4%

3/31 Seres Therapeutics Inc (NASDAQ: MCRB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $8.00 to $7.00. They now have an "outperform" rating on the stock. -6.8%

10/22 Seres Therapeutics Inc (NASDAQ: MCRB) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -6.6%

8/6 Q2/2019 6/30/2019 EPS -0.240 ZacksConsensus -0.410 ActVsEst 0.170 - Beat -6.1%

2/14 Form SC 13G/A Seres Therapeutics, Inc. Filed by: ARK Investment Management LLC -5.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day